Loading...
XCSE
DEMANT
Market cap7.01bUSD
Apr 02, Last price  
226.60DKK
1D
-1.99%
1Q
-15.45%
Jan 2017
84.53%
Name

Demant A/S

Chart & Performance

D1W1MN
P/E
20.22
P/S
2.15
EPS
11.21
Div Yield, %
Shrs. gr., 5y
-2.11%
Rev. gr., 5y
8.45%
Revenues
22.42b
-0.11%
4,522,925,0005,085,055,0005,488,296,0005,373,700,0005,701,200,0006,892,400,0008,041,000,0008,555,000,0009,209,000,0009,346,000,00010,665,000,00012,002,000,00013,189,000,00013,937,000,00014,946,000,00014,469,000,00018,388,000,00019,705,000,00022,443,000,00022,419,000,000
Net income
2.39b
+32.98%
790,586,000900,746,000894,479,000682,400,000794,900,000988,400,0001,199,000,0001,153,000,0001,310,000,0001,326,000,0001,436,000,0001,459,000,0001,754,000,0001,823,000,0001,462,000,0001,121,000,0002,513,000,0002,082,000,0001,795,000,0002,387,000,000
CFO
4.08b
-5.88%
877,049,000946,179,000830,611,000827,700,000950,100,000825,600,0001,381,000,0001,272,000,0001,320,000,0001,495,000,0001,592,000,0001,679,000,0001,872,000,0001,683,000,0002,149,000,0002,621,000,0003,275,000,0002,622,000,0004,335,000,0004,080,000,000

Profile

Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment provides headsets for collaborative work and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
IPO date
May 01, 1995
Employees
21,154
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
22,419,000
-0.11%
22,443,000
13.89%
19,705,000
7.16%
Cost of revenue
18,114,000
18,345,000
16,620,000
Unusual Expense (Income)
NOPBT
4,305,000
4,098,000
3,085,000
NOPBT Margin
19.20%
18.26%
15.66%
Operating Taxes
824,000
839,000
651,000
Tax Rate
19.14%
20.47%
21.10%
NOPAT
3,481,000
3,259,000
2,434,000
Net income
2,387,000
32.98%
1,795,000
-13.78%
2,082,000
-17.15%
Dividends
Dividend yield
Proceeds from repurchase of equity
(2,301,000)
(846,000)
(1,840,000)
BB yield
3.98%
1.28%
4.23%
Debt
Debt current
1,090,000
2,238,000
7,212,000
Long-term debt
17,362,000
14,902,000
10,244,000
Deferred revenue
812,000
635,000
501,000
Other long-term liabilities
674,000
862,000
741,000
Net debt
17,340,000
16,002,000
14,468,000
Cash flow
Cash from operating activities
4,080,000
4,335,000
2,622,000
CAPEX
(576,000)
(846,000)
(924,000)
Cash from investing activities
(1,828,000)
(1,787,000)
(3,328,000)
Cash from financing activities
(2,239,000)
(2,441,000)
934,000
FCF
3,109,000
7,569,000
(4,455,000)
Balance
Cash
1,112,000
1,138,000
1,130,000
Long term investments
1,858,000
Excess cash
15,850
2,002,750
Stockholders' equity
124,000
9,419,000
8,562,000
Invested Capital
26,811,000
25,273,150
22,566,250
ROIC
13.37%
13.62%
11.96%
ROCE
15.69%
15.81%
12.25%
EV
Common stock shares outstanding
218,970
223,130
226,010
Price
264.20
-10.74%
296.00
53.73%
192.55
-42.54%
Market cap
57,851,874
-12.41%
66,046,480
51.77%
43,518,226
-44.70%
EV
75,271,874
82,211,480
57,987,226
EBITDA
5,740,000
5,432,000
4,261,000
EV/EBITDA
13.11
15.13
13.61
Interest
652,000
559,000
195,000
Interest/NOPBT
15.15%
13.64%
6.32%